Mild nephrotoxicity associated with vancomycin use.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Archives of Internal Medicine

• Publication date

  1989-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.1989.00390080053013PMID 2764651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

  1987cited by this paper
• Vancomycin: An Update

  1986cited by this paper
• Vancomycin toxicity: a prospective study.

  1985cited by this paper
• A prospective study of adverse reactions associated with vancomycin therapy.

  1985cited by this paper
• Vancomycin disposition: The importance of age

  1984cited by this paper
• Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

  1983cited by this paper

• Time-Dependent Differences in Vancomycin Sensitivity of Macrophages Underlie Vancomycin-Induced Acute Kidney Injury

  2023cites this paper
• Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoring.

  2023cites this paper
• MRGPRX2 and Adverse Drug Reactions

  2021cites this paper
• Are Blacks at Higher Risk for Vancomycin-Related Acute Kidney Injury?

  2020cites this paper
• Retrospective multicentre matched cohort study comparing safety and efficacy outcomes of intermittent-infusion versus continuous-infusion vancomycin.

  2020cites this paper
• Optimizing the correct timing of vancomycin level collection utilizing a vancomycin medication administration record (MAR) level order

  2020cites this paper
• 9 Vancomycin-Induced Nephrotoxicity

  2020cites this paper
• Utilizing the Patient Care Process to Minimize the Risk of Vancomycin-Associated Nephrotoxicity

  2019cites this paper
• Synergistic and Antagonistic Effects of Phenylalanine and Various Antibiotics on the Growth of Pathogenic Bacteria

  2019cites this paper
• Nephrotoxicity After the Treatment of Periprosthetic Joint Infection With Antibiotic-Loaded Cement Spacers.

  2018cites this paper
• Combination of vancomycin and aminoglycosides is more nephrotoxic than individual agents alone

  2018cites this paper
• Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran

  2018cites this paper
• ASHP Therapeutic Position Statements 685 Therapeutic Monitoring of Vancomycin in Adult Patients : A Consensus Review of the American Society of HealthSystem Pharmacists

  2018cites this paper
• Reducing acute kidney injury due to vancomycin in trauma patients

  2016cites this paper
• The Value of Therapeutic Drug Monitoring of Vancomycin in Treatment in a Tertiary Hospital, Cho Ray Hospital, Viet Nam

  2016cites this paper
• Assessment of Renal Toxicity Associated with Vancomycin in Patients with Health Care-Associated Methicillin-Resistant Staphylococcus Aureus Pneumonia: A Retrospective Analysis

  2016cites this paper
• Retrospective Analysis of Vancomycin Nephrotoxicity in Elderly Chinese Patients

  2015cites this paper
• Vancomycin-Related Problems In Hemodialysis

  2015cites this paper
• Vancomycin-Associated Nephrotoxicity: The Obesity Factor

  2015cites this paper
• Multidrug-Resistant Gram-Positive Bacterial Infections

  2015cites this paper
• Acute Kidney Injury in Cancer Patients

  2014cites this paper
• Innovative approaches to optimizing the delivery of vancomycin in individual patients.

  2014cites this paper
• Vancomycin‐Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors

  2014cites this paper
• Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study

  2013cites this paper
• Effect of defibrillation threshold testing-induced ventricular fibrillation on renal function

  2013cites this paper
• An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort.

  2013cites this paper
• Development of acute kidney injury during continuous infusion of vancomycin in septic patients

  2013cites this paper
• Nephrotoxicity in Patients with Vancomycin Trough Concentrations of 15–20 μg/ml in a Pediatric Intensive Care Unit

  2013cites this paper
• Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans.

  2012cites this paper
• Teicoplanin

  2012cites this paper
• Economic Aspects of Antibacterial Adverse Effects

  2012cites this paper
• Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review

  2012cites this paper
• [Not Available].

  2011cites this paper
• Niveau de preuve pour le suivi thérapeutique pharmacologique de la vancomycine

  2011cites this paper
• [Level of evidence for therapeutic drug monitoring of vancomycin].

  2011cites this paper
• Cochrane meta-analysis: teicoplanin versus vancomycin for proven or suspected infection.

  2011cites this paper
• Nephrotoxicity of vancomycin in patients with methicillin‐resistant Staphylococcus aureus bacteraemia

  2011cites this paper
• Oral infections and antibiotic therapy.

  2011cites this paper
• Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15–20 mg/L Suggested by the Vancomycin Consensus Guidelines

  2011cites this paper
• Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), and Lipopeptides (Daptomycin)

  2010cites this paper
• Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?

  2010cites this paper
• Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.

  2010cites this paper
• Teicoplanin versus vancomycin for proven or suspected infection.

  2010cites this paper
• Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

  2009cites this paper
• Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

  2009cites this paper
• Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

  2008cites this paper
• Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.

  2008cites this paper
• Gene Expression Analysis Reveals New Possible Mechanisms of Vancomycin-Induced Nephrotoxicity and Identifies Gene Markers Candidates

  2008influential citation
• A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.

  2007cites this paper
• Infectious Diseases: Pharmacologic Treatment Options for Nosocomial Pneumonia Involving Methicillin-Resistant Staphylococcus aureus

  2007cites this paper
• Nephrotoxicity of Vancomycin and Teicoplanin Alone and in Combination with an Aminoglycoside

  2007cites this paper
• 腎機能別の過量投与危険率を根拠とした塩酸バンコマイシン(VCM)初期投与量設定法

  2006cites this paper
• Nephrotoxicity due to Combination Antibiotic Therapy with Vancomycin and Aminoglycosides in Septic Critically Ill Patients

  2006cites this paper
• Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity.

  2005cites this paper
• Factors Influencing the Overestimation of Plasma Vancomycin Concentrations Measured by the Abbott TDx Technique

  2005cites this paper
• Nephrotoxicity with combination vancomycin-aminoglycoside therapy.

  2005cites this paper
• Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.

  2003cites this paper
• Mississippi Mud No More: Cost‐Effectiveness of Pharmacokinetic Dosage Adjustment of Vancomycin to Prevent Nephrotoxicity

  2003cites this paper
• Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.

  2001cites this paper
• Outbreak of acute renal failure due to cefodizime-vancomycin association in a heart surgery unit

  2001cites this paper
• [Examination of factors affecting efficacy and adverse effect, for the retrospective study of vancomycin hydrochloride (VCM)].

  2001cites this paper
• Limitations of presently available glycopeptides in the treatment of Gram-positive infection.

  2001cites this paper
• Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.

  2000cites this paper
• A case with acute empyema followed by multiple brain abscesses during tube drainage.

  1999cites this paper
• Association of Serum Vancomycin Concentration with Renal Dysfunction

  1999influential citation
• Vancomycin-Induced Acute Interstitial Nephritis

  1998cites this paper
• Acute illness superimposed on chronic renal failure

  1998cites this paper
• Influence of glycopeptide antibiotics on purine metabolism of endothelial cells.

  1998cites this paper
• Laboratory guidelines for monitoring of antimicrobial drugs

  1998cites this paper
• Aminoglycosides and vancomycin

  1998cites this paper
• Mississippi mud in the 1990s

  1998cites this paper
• Laboratory guidelines for monitoring of antimicrobial drugs. National Academy of Clinical Biochemistry.

  1998cites this paper
• Drug Administration in Patients with Renal Insufficiency

  1997cites this paper
• A closer look at vancomycin, teicoplanin, and antimicrobial resistance.

  1997cites this paper
• Use of Aminoglycosides in Elderly Patients

  1997cites this paper
• The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S‐mephenytoin

  1997cites this paper
• Vancomycin Serum Concentration Monitoring

  1996cites this paper
• Cystic fibrosis pulmonary infections

  1996cites this paper
• Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia

  1996cites this paper
• Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.

  1996cites this paper
• Cost‐effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies

  1996cites this paper
• Lack of effect of vancomycin and gentamicin on auditory function in guinea pigs

  1996cites this paper
• Rationalization of Vancomycin Serum Concentration Monitoring

  1995cites this paper
• Association of Vancomycin Serum Concentrations With Outcomes in Patients With Gram‐Positive Bacteremia

  1995cites this paper
• Pharmacokinetic Optimisation of Vancomycin Therapy

  1995cites this paper
• Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.

  1995cites this paper
• Therapeutic Drug Monitoring in Pediatrics: A Need for Improvement

  1994cites this paper
• Teicoplanin: 10 years of clinical experience.

  1994cites this paper
• Vancomycin toxicity. What is the evidence for dose dependency?

  1994cites this paper
• A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient.

  1994cites this paper
• Teicoplanin: 10 years of clinical experience

  1994cites this paper
• A Pharmacoeconomic Model to Evaluate Antibiotic Costs

  1994cites this paper
• Glycopeptides and nephrotoxicity

  1994cites this paper
• Serum vancomycin concentrations: reappraisal of their clinical value.

  1994cites this paper
• In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci

  1993cites this paper
• Prospective Assessment of Nephrotoxicity with Concomitant Aminoglycoside and Vancomycin Therapy

  1993cites this paper
• InVitro Activities ofRamoplanin, Selected Glycopeptides, Fluoroquinolones, andOtherAntibiotics against Clinical Bloodstream Isolates ofGram-Positive Cocci

  1993cites this paper
• Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination.

  1993cites this paper
• Simplified dosing and monitoring of vancomycin for the burn care clinician.

  1992cites this paper
• Vancomycin, metronidazole, and tetracyclines.

  1992cites this paper